These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 29563198

  • 1. Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa.
    Sader HS, Rhomberg PR, Huband MD, Critchley IA, Stone GG, Flamm RK, Jones RN.
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563198
    [Abstract] [Full Text] [Related]

  • 2. Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg.
    Koeth LM, Matuschek E, Kahlmeter G, Stone G.
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1047-1053. PubMed ID: 29603034
    [Abstract] [Full Text] [Related]

  • 3. Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against Enterobacterales Clinical Isolates.
    Han R, Yang X, Yang Y, Guo Y, Yin D, Ding L, Wu S, Zhu D, Hu F.
    Microbiol Spectr; 2022 Feb 23; 10(1):e0109221. PubMed ID: 35019685
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China.
    Wang Q, Zhang F, Wang Z, Chen H, Wang X, Zhang Y, Li S, Wang H.
    BMC Microbiol; 2020 Jun 29; 20(1):187. PubMed ID: 32600252
    [Abstract] [Full Text] [Related]

  • 5. In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015.
    Karlowsky JA, Kazmierczak KM, Bouchillon SK, de Jonge BLM, Stone GG, Sahm DF.
    Antimicrob Agents Chemother; 2018 Jul 29; 62(7):. PubMed ID: 29760124
    [Abstract] [Full Text] [Related]

  • 6. Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa.
    Shields RK, Clancy CJ, Pasculle AW, Press EG, Haidar G, Hao B, Chen L, Kreiswirth BN, Nguyen MH.
    J Clin Microbiol; 2018 Feb 29; 56(2):. PubMed ID: 29167294
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016.
    Sader HS, Castanheira M, Shortridge D, Mendes RE, Flamm RK.
    Antimicrob Agents Chemother; 2017 Nov 29; 61(11):. PubMed ID: 28827415
    [Abstract] [Full Text] [Related]

  • 8. Ceftazidime-Avibactam Antimicrobial Activity and Spectrum When Tested Against Gram-negative Organisms From Pediatric Patients: Results From the INFORM Surveillance Program (United States, 2011-2015).
    Sader HS, Huband MD, Duncan LR, Flamm RK.
    Pediatr Infect Dis J; 2018 Jun 29; 37(6):549-554. PubMed ID: 29206750
    [Abstract] [Full Text] [Related]

  • 9. Performance of the Etest for Susceptibility Testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa toward Ceftazidime-Avibactam.
    Kresken M, Körber-Irrgang B.
    J Clin Microbiol; 2018 Sep 29; 56(9):. PubMed ID: 29899002
    [No Abstract] [Full Text] [Related]

  • 10. Correlation between Broth Microdilution and Disk Diffusion Results when Testing Ceftazidime-Avibactam against a Challenge Collection of Enterobacterales Isolates: Results from a Multilaboratory Study.
    Sader HS, Rhomberg PR, Chandrasekaran S, Trejo M, Fedler KA, Boyken LD, Diekema DJ.
    J Clin Microbiol; 2020 Mar 25; 58(4):. PubMed ID: 31996445
    [Abstract] [Full Text] [Related]

  • 11. A Systematic Approach to the Selection of the Appropriate Avibactam Concentration for Use with Ceftazidime in Broth Microdilution Susceptibility Testing.
    Bradford PA, Huband MD, Stone GG.
    Antimicrob Agents Chemother; 2018 Jul 25; 62(7):. PubMed ID: 29735568
    [Abstract] [Full Text] [Related]

  • 12. Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa.
    Nichols WW, Stone GG, Newell P, Broadhurst H, Wardman A, MacPherson M, Yates K, Riccobene T, Critchley IA, Das S.
    Antimicrob Agents Chemother; 2018 Nov 25; 62(11):. PubMed ID: 30061279
    [Abstract] [Full Text] [Related]

  • 13. Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014).
    Sader HS, Castanheira M, Farrell DJ, Flamm RK, Jones RN.
    Diagn Microbiol Infect Dis; 2015 Dec 25; 83(4):389-94. PubMed ID: 26162518
    [Abstract] [Full Text] [Related]

  • 14. In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015.
    Karlowsky JA, Kazmierczak KM, Bouchillon SK, de Jonge BLM, Stone GG, Sahm DF.
    Antimicrob Agents Chemother; 2019 Apr 25; 63(4):. PubMed ID: 30670424
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial susceptibility testing of Enterobacteriaceae: determination of disk content and Kirby-Bauer breakpoint for ceftazidime/avibactam.
    Yang X, Wang D, Zhou Q, Nie F, Du H, Pang X, Fan Y, Bai T, Xu Y.
    BMC Microbiol; 2019 Nov 01; 19(1):240. PubMed ID: 31675928
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012.
    Sader HS, Castanheira M, Flamm RK, Farrell DJ, Jones RN.
    Antimicrob Agents Chemother; 2014 Nov 01; 58(3):1684-92. PubMed ID: 24379201
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections.
    Stone GG, Bradford PA, Yates K, Newell P.
    J Antimicrob Chemother; 2017 May 01; 72(5):1396-1399. PubMed ID: 28088768
    [Abstract] [Full Text] [Related]

  • 18. Activity of ceftazidime-avibactam against fluoroquinolone-resistant Enterobacteriaceae and Pseudomonas aeruginosa.
    Pitart C, Marco F, Keating TA, Nichols WW, Vila J.
    Antimicrob Agents Chemother; 2015 May 01; 59(6):3059-65. PubMed ID: 25753646
    [Abstract] [Full Text] [Related]

  • 19. Ceftazidime-avibactam activity against multidrug-resistant Pseudomonas aeruginosa isolated in U.S. medical centers in 2012 and 2013.
    Sader HS, Castanheira M, Mendes RE, Flamm RK, Farrell DJ, Jones RN.
    Antimicrob Agents Chemother; 2015 May 01; 59(6):3656-9. PubMed ID: 25845861
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS, Castanheira M, Flamm RK.
    Antimicrob Agents Chemother; 2017 Apr 01; 61(4):. PubMed ID: 28069649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.